GLOW: composition, components and handling

A blend vial contains more than one molecular entity, combined before lyophilization. GLOW is not a single compound with three activities; it is three separate peptides sharing a container, and each retains its own structure, molecular weight and stability profile.

HEEZ publishes the identity of GLOW's three components and the total vial mass of 70 mg. It does NOT publish a per-component split — the milligram quantity of each individual peptide within that 70 mg is not stated on the listing.

That distinction matters and is worth being explicit about: any per-component figure for GLOW circulating elsewhere is inference rather than published specification. Where a protocol requires known quantities of individual components, the single-compound listings are the appropriate source, since each is sold separately in the catalogue.

By contrast the Wolverine blend does publish its split — 5 mg BPC-157 and 5 mg TB-500 in a 10 mg vial — which shows the difference is a deliberate disclosure decision per product rather than a general policy.

GHK-Cu is a copper peptide: the tripeptide glycyl-L-histidyl-L-lysine complexed with copper(II). Three residues make it the shortest component in the blend by a considerable margin.

The copper is not an incidental contaminant but a coordinated part of the molecule, held by the histidine imidazole nitrogen and the peptide backbone. That coordination is what distinguishes GHK-Cu from uncomplexed GHK, and it is also the origin of the blue colour characteristic of copper peptides.

In a blend context the copper complex is the component with the most distinctive handling profile, since copper coordination chemistry is sensitive to pH and to chelating agents in a way the other two components are not.

BPC-157 is a pentadecapeptide — fifteen residues — whose sequence reproduces a partial region of body protection compound, a protein identified in gastric juice. It is a linear peptide with free termini and no modification.

TB-500 is a synthetic peptide corresponding to the characterized region of thymosin beta-4, a naturally occurring 43-amino-acid protein. TB-500 is the shorter synthetic construct rather than the full-length protein, and the two are related by sequence without being the same entity.

Both are supplied separately in the HEEZ catalogue as well as within blends, so their individual certificates and specifications are available independently of GLOW's.

GLOW is supplied as a single 70 mg lyophilized vial. That figure is the total mass of blended peptide material, not the mass of any one component.

Lyophilization removes water and leaves the blend as a solid cake. As with single-compound vials, the dried form is substantially more stable than solution and tolerates ambient transit without a cold chain.

KLOW, the related blend, is an 80 mg vial containing the same three components plus KPV. The 10 mg difference between the two vials should not be read as the mass of the added component, since no per-component split is published for either.

The arithmetic is the same as for a single compound, but the quantity it applies to is different. Concentration equals mass over volume, and for GLOW the mass is the 70 mg total. Reconstituting with 2 ml gives 35 mg per ml of blended material; with 3.5 ml, 20 mg per ml.

What this produces is a known concentration of the blend as a whole, not of any individual component. Because no per-component split is published, a component-specific concentration cannot be derived from the vial mass, and attempting to calculate one would be building on an assumption rather than a specification.

peptcalc.com handles the total-mass calculation directly: enter 70 mg and the target blend concentration and it returns the diluent volume.

Bacteriostatic water is the usual diluent where the vial will be entered more than once. Diluent is added down the vial wall and the vial swirled rather than shaken, as for any lyophilized peptide.

Sealed lyophilized GLOW is ambient-stable through transit, so no cold chain or insulated packaging is used in shipping. On receipt the vial is refrigerated and kept out of light.

Light protection is worth particular attention for this blend, because the copper complex in GHK-Cu is more light-sensitive than an unmodified peptide. Storage in the dark is standard practice regardless, and here there is a specific reason for it.

Reconstituted blend is refrigerated and used within the window the receiving facility's protocols specify. A multi-component solution is only as stable as its least stable component, so the shortest applicable window governs.

The certificate for a blend covers the blended material as supplied, and its lot number must match the vial in hand as with any batch-specific document.

Reading a blend certificate differs from reading a single-compound one. Identity confirmation addresses the components present, and a chromatogram of a three-component blend shows multiple peaks by design rather than one main peak with impurities — so the single purity percentage familiar from a single compound does not carry the same meaning.

Where a protocol requires component-level documentation, the single-compound listings for GHK-Cu, BPC-157 and TB-500 each carry their own certificates, and those are the appropriate reference.